{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Examining the drug supply chain :
hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, December 13, 2017.
Examining The Drug Supply Chain : Hearing Before The Subcommittee On Health Of The Committee On Energy And Commerce, House Of Representatives, One Hundred Fifteenth Congress, First Session, December 13, 2017.
United States.
U.S. Government Publishing Office,
2018.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain :
hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
Examining The Impact Of Voluntary Restricted Distribution Systems In The Pharmaceutical Supply Chain : Hearing Before The Subcommittee On Healthcare, Benefits, And Administrative Rules Of The Committee On Oversight And Government Reform, House Of Representatives, One Hundred Fifteenth Congress, First Session, March 22, 2017.
United States.
U.S. Government Publishing Office,
2017.
